» Authors » K J Lafferty

K J Lafferty

Explore the profile of K J Lafferty including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 161
Citations 1327
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dilts S, Solvason N, Lafferty K
J Autoimmun . 1999 Nov; 13(3):285-90. PMID: 10550215
No abstract available.
2.
Dilts S, Lafferty K
J Autoimmun . 1999 May; 12(4):229-32. PMID: 10330293
Our studies in the NOD mouse demonstrate that the autoimmune response can be either benign or malignant. In the former case </=10% of the islets in the pancreas are damaged....
3.
Lafferty K
Transplant Proc . 1999 Mar; 31(1-2A):11S-13S. PMID: 10078219
No abstract available.
4.
Calcinaro F, Gambelunghe G, Lafferty K
Immunol Cell Biol . 1998 Jan; 75(5):467-71. PMID: 9429894
Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease that is characterized by the destruction of insulin-producing beta-cells in the pancreatic islets. A single administration of CFA prevents clinical hyperglycaemia in...
5.
Desai N, Korbutt G, Barker C, Lafferty K
Diabetologia . 1997 Nov; 40 Suppl 3:B44-9. PMID: 9345645
No abstract available.
6.
Lafferty K
Res Immunol . 1997 Jun; 148(5):313-9. PMID: 9352595
No abstract available.
7.
Gazda L, Charlton B, Lafferty K
J Autoimmun . 1997 Jun; 10(3):261-70. PMID: 9218753
IDDM in the NOD mouse is the result of a chronic autoimmune process. NOD mice are shown to express benign autoimmunity that converts to a state of malignant autoimmunity and...
8.
Lafferty K, Gazda L
Hum Immunol . 1997 Feb; 52(2):119-26. PMID: 9077560
The clonal selection theory of immune reactivity is based on a metaphor of self/not-self discrimination and considers self-tolerance to result from clonal deletion. There is evidence that a deletional mechanism...
9.
Coulombe M, Yang H, Guerder S, Flavell R, Lafferty K, Gill R
J Immunol . 1996 Dec; 157(11):4790-5. PMID: 8943380
Pancreatic islet transplantation represents a potential treatment for insulin-dependent diabetes mellitus. One approach to circumvent the requirement for recipient immune suppression is to reduce or eliminate the immunogenicity of the...
10.
Gazda L, Baxter A, Lafferty K
Immunol Cell Biol . 1996 Oct; 74(5):401-7. PMID: 8912002
Non-islet-antigen specific treatments have been shown to alter the natural history of insulin dependent diabetes in both the non-obese diabetic (NOD) mouse and in recently diagnosed patients. However concerns have...